|
WO2007139827A2
|
|
Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses
|
|
AU2002347863A1
|
|
Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions
|
|
WO02085437A1
|
|
System and method for total liquid ventilation with very low priming volume
|
|
EP1377204A2
|
|
Physiological object displays
|
|
AU5775101A
|
|
Stabilized microbubble compositions for ultrasound
|
|
AU4381301A
|
|
Harmonic ultrasound imaging with microbubbles
|
|
WO0185136A2
|
|
Phospholipid-based powders for drug delivery
|
|
AU1664801A
|
|
Methods and apparatus for reducing loss of respiratory promoters
|
|
US6743172B1
|
|
System and method for displaying medical process diagrams
|
|
AU6651100A
|
|
Continuous fluorochemical microdispersions for the delivery of pharmaceutical agents
|
|
AU4264100A
|
|
Hemodilution facilitated by mounting oxygenation status
|
|
US2002103165A1
|
|
Engineered spray-dried lipid-based microparticles for cellular targeting
|
|
AU1759000A
|
|
Gas emulsions stabilized with flourinated ethers having low Ostwald coefficients
|
|
EP1083982A1
|
|
Liquid breathing-gas exchanger
|
|
WO0000215A1
|
|
Particulate delivery systems and methods of use
|
|
AU2666799A
|
|
System for displaying medical process diagrams
|
|
US6679859B1
|
|
Amelioration of ischemic damage using synthetic oxygen carriers
|
|
WO9921541A2
|
|
Amelioration of ischemic damage using synthetic oxygen carriers
|
|
AU8933898A
|
|
Stablized microbubble compositions for ultrasound
|
|
WO9916492A1
|
|
Detection of oxygen carriers in exhaled gases
|
